Ieq Capital, LLC Abb Vie Inc. Transaction History

Ieq Capital, LLC

$8.04 Billion
Q3 2024

A detailed history of Ieq Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ieq Capital, LLC holds 111,709 shares of ABBV stock, worth $19.6 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

111,709

Previous 104,556 6.84%

Holding current value

$19.6 Million

Previous $17.9 Million 23.01%

% of portfolio

0.27%

Previous 0.24%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $1.17 Million - $1.43 Million	7,153 Added 6.84%	111,709 $22.1 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $3.96 Million - $4.62 Million	-25,552 Reduced 19.64%	104,556 $17.9 Million
Q1 2024 May 08, 2024	BUY	$159.82 - $182.1 $6.47 Million - $7.37 Million	40,467 Added 45.14%	130,108 $23.7 Million
Q4 2023 Feb 07, 2024	BUY	$137.6 - $154.97 $58,204 - $65,552	423 Added 0.47%	89,641 $13.9 Million
Q3 2023 Nov 03, 2023	BUY	$133.59 - $154.65 $1.18 Million - $1.37 Million	8,860 Added 11.03%	89,218 $13.3 Million
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $2.2 Million - $2.74 Million	-16,634 Reduced 17.15%	80,358 $10.8 Million
Q1 2023 May 01, 2023	SELL	$144.61 - $166.54 $461,595 - $531,595	-3,192 Reduced 3.19%	96,992 $15.5 Million
Q4 2022 Feb 03, 2023	BUY	$138.31 - $165.87 $1.36 Million - $1.63 Million	9,855 Added 10.91%	100,184 $16.2 Million
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $1.4 Million - $1.6 Million	10,415 Added 13.03%	90,329 $12.1 Million
Q2 2022 Jul 27, 2022	BUY	$137.62 - $174.96 $269,735 - $342,921	1,960 Added 2.51%	79,914 $12.2 Million
Q1 2022 Apr 26, 2022	BUY	$131.98 - $163.75 $1.36 Million - $1.68 Million	10,278 Added 15.19%	77,954 $12.6 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $838,920 - $1.06 Million	7,809 Added 13.04%	67,676 $9.16 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $321,540 - $364,997	3,022 Added 5.32%	59,867 $6.46 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $1.05 Million - $1.17 Million	9,991 Added 21.32%	56,845 $6.4 Million
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $229,663 - $252,831	2,245 Added 5.03%	46,854 $5.07 Million
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $61,574 - $83,132	765 Added 1.74%	44,609 $4.78 Million
Q3 2020 Nov 03, 2020	SELL	$85.91 - $100.83 $384,876 - $451,718	-4,480 Reduced 9.27%	43,844 $3.84 Million
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $160,680 - $215,014	2,190 Added 4.75%	48,324 $4.74 Million
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $2,644 - $4,009	41 Added 0.09%	46,134 $3.52 Million
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $265,943 - $332,751	-3,687 Reduced 7.41%	46,093 $4.08 Million
Q4 2019 Feb 04, 2020	BUY	$72.13 - $90.25 $3.59 Million - $4.49 Million	49,780 New	49,780 $3.83 Million

Others Institutions Holding ABBV

# of Institutions

3,877

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.

Account